GeminIQ Website Logo

Viewing USRM free

Subscribe for full history, 90+ metrics, screener, watchlist...

U.S. Stem Cell, Inc.

USRM

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
000000000000
Accounts Receivable Net Current
000000000000
Assets Current
Assets Current
000000010000
Inventory Net
000000000000
Prepaid Expense And Other Assets Current
000000000000
Investments
--------0000
Assets
000000010000
Liabilities And Stockhold…
Accounts Payable Current
222211111111
Accrued Liabilities Current
322222222111
Bank Overdrafts
--------0000
Due To Related Parties Current
-11111111111
Deferred Gain On Sale Of Property
-------00000
Other Liabilities Current
1---1-------
Deferred Revenue Current
0000000-0000
Liabilities Current
Deposit Liability Current
000000000000
Liabilities Current
14141313121211111110109
Notes Payable Related Parties Classified Current
-44333333433
Notes Payable
4---3-------
Long Term Debt And Capital Lease Obligations Curre…
333333333111
Notes Payable Current
111111111111
Convertible Notes Payable Current
000000000000
Liabilities Noncurrent
Liabilities Noncurrent
111111111111
Deferred Revenue Noncurrent
000000000000
Long Term Notes Payable
111111111111
Liabilities
151414141312121212111010
Preferred Stock Value
000000000000
Stockholders Equity
Common Stock Value
111110000000
Stockholders Equity
-15-14-14-13-13-12-12-11-12-11-10-10
Additional Paid In Capital
127127127127127126126126124124124124
Retained Earnings Accumulated Deficit
-143-142-141-141-140-139-138-137-137-136-135-134
Liabilities And Stockholders Equity
000000010000
Allowance For Doubtful Accounts Receivable Current
000000--0---
Debt Instrument Unamortized Discount
-----0000000
Debt Instrument Unamortized Discount Current
-000--------
Debt Instrument Unamortized Discount Noncurrent
0---0---0---
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
202020202020202020202020
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
2,0002,0002,0002,0002,0002,0002,0002,0002,0002,0002,0002,000
Common Stock Shares Issued
634632598592504461452450436430428425
Shares Outstanding
634632598592504461452450436430428425

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2022-16.13%-12.90%-1.77%19.01%-17.36%-12.40%-19.23%-7.69%-13.46%-16.67%-39.90%-30.56%
20210.54%0.00%-5.38%0.00%-5.38%-11.54%-28.33%-50.00%-41.67%-22.87%-28.72%-44.68%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.06
0.01
0.01
0.02
0.01
Quick Ratio
0.00
0.00
0.00
0.00
0.00
0.01
0.02
0.05
0.01
0.01
0.02
0.01
Working Capital
-14.01M
-13.46M
-13.10M
-12.60M
-11.99M
-11.55M
-11.09M
-10.32M
-10.76M
-10.35M
-9.36M
-9.08M
Leverage & Debt
Debt to Equity
-1.00
-1.01
-1.01
-1.01
-1.00
-1.01
-1.02
-1.06
-1.01
-1.01
-1.02
-1.01
Interest Coverage TTM
-2.49
-1.68
-1.80
-2.16
-2.14
-3.49
-4.33
-4.25
-4.91
-6.06
-8.46
-5.26
Debt Ratio
217.72
83.62
195.93
94.90
251.33
153.41
60.82
18.35
132.36
95.65
50.98
105.69
Efficiency & Turnover
Asset Turnover TTM
1.38
0.68
0.95
0.36
2.89
2.94
1.49
0.83
3.11
1.22
1.04
2.70
Days Sales Outstanding TTM
12.33
81.30
59.57
145.56
50.34
35.22
34.25
85.51
67.43
16.17
11.18
10.00
Receivables Turnover TTM
29.59
4.49
6.13
2.51
7.25
10.36
10.66
4.27
5.41
22.57
32.66
36.50
Per Share Metrics
Free Cash Flow Per Share TTM
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
71.03%
67.93%
71.72%
68.61%
74.08%
81.55%
80.54%
79.75%
76.86%
52.55%
39.19%
54.35%
Operating Profit Margin TTM
-2,096.90%
-1,994.81%
-1,411.34%
-1,548.79%
-1,063.94%
-756.86%
-901.34%
-786.00%
-866.24%
-604.60%
-613.23%
-193.08%
Net Profit Margin TTM
-3,483.21%
-3,422.93%
-2,360.60%
-2,479.60%
-1,637.58%
-1,106.54%
-1,240.78%
-1,083.79%
-1,043.17%
-632.64%
-616.38%
-205.27%
Growth Metrics
Net Revenue Growth (1Y)
-59.13%
-70.71%
-57.05%
-54.05%
-27.55%
-37.87%
-46.72%
-83.31%
-90.98%
-89.37%
-90.26%
-71.08%
Net Income Growth (1Y)
-13.06%
-9.39%
-18.28%
5.13%
13.73%
8.67%
7.25%
-11.86%
-24.64%
-17.38%
51.50%
38.72%
EPS Growth (1Y)
-31.00%
-33.90%
-38.28%
-19.99%
-1.62%
1.25%
1.61%
-16.85%
-27.72%
-23.52%
39.36%
27.21%
Valuation Metrics
P/E TTM
-1.07
-1.32
-1.10
-1.61
-0.92
-1.58
-1.87
-6.84
-1.84
-0.62
-0.74
-0.78
P/B TTM
-0.21
-0.27
-0.24
-0.42
-0.24
-0.41
-0.59
-2.02
-0.46
-0.17
-0.25
-0.30
P/S TTM
37.11
45.02
26.01
39.83
15.05
17.51
23.21
74.09
19.18
3.93
4.56
1.61
Market Cap
3.05M
3.86M
3.35M
5.56M
3.02M
5.12M
6.96M
22.52M
5.31M
1.85M
2.57M
2.93M
Enterprise Value
11.99M
8.87M
8.38M
10.63M
11.00M
9.90M
11.65M
26.88M
10.06M
5.37M
6.02M
6.35M
Calculated Values
Free Cash Flow TTM
-304.85K
-478.49K
-619.82K
-804.23K
-1.06M
-962.27K
-952.01K
-701.74K
-478.89K
-577.71K
-837.29K
-965.24K
Net Debt
8.94M
5.02M
5.03M
5.06M
7.98M
4.78M
4.69M
4.36M
4.74M
3.53M
3.45M
3.42M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2017-08-17Purchase
Owner: Murphy, William P Jr
Title: -
Shares: 1,799,614
Price/Share: $0.03
Value: $53,988.42
Shares Owned: 2,088,818
Relationship: Director
Ownership: Direct
2017-03-06Purchase
Owner: Murphy, William P Jr
Title: -
Shares: 1,200,000
Price/Share: $0.02
Value: $24,000.00
Shares Owned: 1,274,835
Relationship: Director
Ownership: Indirect
2015-11-12Purchase
Owner: Murphy, William P Jr
Title: -
Shares: 825
Price/Share: -
Value: -
Shares Owned: 43,430
Relationship: Director,TenPercentOwner
Ownership: Direct
2015-11-10Purchase
Owner: Murphy, William P Jr
Title: -
Shares: 1,000
Price/Share: $1.40
Value: $1,400.00
Shares Owned: 42,605
Relationship: Director,TenPercentOwner
Ownership: Direct
2015-11-06Purchase
Owner: Ahn, Samuel S
Title: -
Shares: 411
Price/Share: -
Value: -
Shares Owned: 42,806
Relationship: Director
Ownership: Direct

Subscribe to unlock 17+ years of data

No institutional ownership data available.

U.S. Stem Cell, Inc. (USRM) — SEC Financial Statements & Analysis

U.S. Stem Cell, Inc. (USRM) is a services-commercial physical & biological research company, incorporated in FL. U.S. Stem Cell, Inc. trades on OTC as: USRM. Based on its latest SEC filing (Form 10-Q, period ending 2022-12-31), U.S. Stem Cell, Inc. reported a -59.13% year-over-year revenue growth, a Gross Profit Margin of 71.03% (TTM), a Debt-to-Equity ratio of -1.00x, a Price-to-Sales (P/S) ratio of 37.11x (TTM), a Price-to-Book (P/B) ratio of -0.21x (TTM), at a market cap of $3.05M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-59.13%
Gross Profit Margin TTM
71.03%
Debt To Equity
-1.00x
P/S TTM
37.11x
P/B TTM
-0.21x
Market Cap
$3.05M

Data as of 2022-12-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is U.S. Stem Cell, Inc. in?

U.S. Stem Cell, Inc. (USRM) operates in the Services-Commercial Physical & Biological Research industry.

What is USRM's market cap?

U.S. Stem Cell, Inc. (USRM) has a market capitalization of $3.05M as of 2022-12-31.

What exchange does USRM trade on?

U.S. Stem Cell, Inc. (USRM) trades on the OTC.

Where is U.S. Stem Cell, Inc. incorporated?

U.S. Stem Cell, Inc. is incorporated in FL.

Wall Street's data.
Main Street's price.